Medtronic Prostiva 8930 Guía Para El Usuario página 92

8930EN_5.fm 12/17/10 2:44 pm
UCxxxxxx EN
7 x 9 inches (178 mm x 229 mm)
Chapter 5
92
Overview
Table 5-3. Total Symptom Score Overview
Visit
Pretreatment
1 Month
3 Months
6 Months
12 Months
Table 5-4. Peak Uroflow Rate (Qmax) Overview
Visit
Pretreatment
1 Month
3 Months
6 Months
12 Months
English 8930 System User Guide 2010-12
MA07445A008 Rev X
Similar results were seen from the additional studies (lateral and
median lobes). Tables 5-3 and 5-4 demonstrated the efficacy
results of all the studies.
Original TUNA
Therapy Lateral Lobe Median Lobe Studies
Studies (American
Urological Prostate Symptom
Association
Symptom Score)
24.6
12.5
9.6
10.1
10.6
Original TUNA
Therapy Lateral Lobe Median Lobe Studies
Studies (American
Urological Prostate Symptom
Association
Symptom Score)
8.306
16.565
15.024
14.748
13.432
P01 Lateral and PM1 Lateral and
Median Lobe Studies
(International (International
Prostate Symptom
Score)
21.0
16.0
10.0
10.0
11.0
P01 Lateral and PM1 Lateral and
Median Lobe Studies
(International (International
Prostate Symptom
Score)
8.6
10.2
12.0
13.7
12.7
Medtronic Confidential
CRMRef_R06
Score)
24.0
13.0
10.0
5.0
N/A
Score)
6.4
11.4
15.1
11.0
N/A